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INTRODUCTION 
 Local anesthesia forms the fortitude of pain control techniques in 
dentistry. They are chemicals that block the nerve conduction in a specific, 
temporary, and completely reversible manner without affecting the 
consciousness of the patient. Though cocaine has significant limitations like it 
has as a low therapeutic index, the risk of addiction and potentially lethal 
arrhythmias, it was the drug of choice for the control of surgical and dental 
pain until the beginning of the twentieth century. New amino amide local 
anesthetics were synthesized between 1891 and 1930, such as Tropicalize, 
Holocaine, Benzocaine, and Tetracaine. In addition, amino amide local 
anesthetics were prepared between 1898 and 1972, including Procaine, 
Chloropropane, Cinchocaine, Lidocaine, Mepivacaine, Prilocaine, 
Bupivacaine, Etidocaine, and Articaine.59 
In 1904, Alfred Einhorn synthesized Procaine that became the main 
local anesthetic in medicine and dentistry. Later in 1943, Nils Lofgren 
synthesized Lidocaine which was the first amide anesthetic prepared for local 
application. With the progressive introduction of Cocaine (1884), Procaine 
(1904), Lidocaine (1949), dentistry has been in the leading edge to provide 
patients with pain-free care.42  
One of the most important prerequisites of dentistry is to achieve 
effective pain control during dental procedures. Lidocaine was marketed in 
1948 and is presently the most commonly used local anesthetic in dentistry 
worldwide as it was more potent and less allergenic than Procaine. In the 
succeeding years, another amide local anesthetics (Prilocaine in 1953 by 
Lofgren and Tegner, Bupivacaine and Mepivacaine in 1957 by A.F Ekenstam, 
Etidocaine in 1971 by Takman) were introduced. Because of its high efficacy 
and safety, Lidocaine has become the gold standard drug among the newer 
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local anesthetic agents.  The local anesthetics used in dentistry are classified 
based on their chemical structure into amides and esters. Unlike ester agents 
amides produce more rapid and reliable profound surgical anesthesia. 
Articaine hydrochloride was synthesized by Rusching et al. in 1969 under the 
name Carticaine and was first marketed in Germany (1976). Articaine differs 
from the previous amide local anesthetics in that it has a thiophene ring in its 
molecule instead of the usual aromatic ring which imparts Articaine more lipid 
solubility.52 Articaine being a relatively new drug, which needs to be tested to 
be used as widely accepted anesthesia drug worldwide.  
      Bhagat et al.8 conducted a study to compare the anesthetic efficacy of 
both 4% Articaine and 2% Lignocaine with epinephrine in the truncal block of 
the inferior alveolar nerve during surgical removal of the impacted mandibular 
third molars and opined that 4% Articaine has better anesthetic efficacy as 
compared to 2% Lignocaine. Batista da Silva et al.7 conducted a study to 
compare the anesthetic efficacy of 4% Articaine and 2% Lidocaine both with 
1:100,000 epinephrine concentration administered as inferior mandibular 
nerve block and observed that the duration of anesthesia for Lignocaine was 
135.5–184.5 min and 145.75–198.75 min for Articaine and providing higher 
anesthetic success rate and longer duration of anesthesia than Lidocaine. 
Shruthi et al.56 conducted a study to compare the efficacy of Articaine 
with that of lidocaine and found out that Articaine has similar efficacy as that 
of Lignocaine with slightly longer duration and can be used as an alternative 
to Lignocaine in the third molar surgery. Tortamano et al.10 found a higher 
success rate with Articaine in pulpectomy of mandibular posterior teeth by 
inferior alveolar nerve block than Lignocaine. Kanaa et al.11 found in his study 
that Articaine buccal infiltration along with inferior alveolar nerve block was 
more successful than it was with inferior alveolar nerve block alone. 
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Supplemental injections are essential when, as frequently occurs in patients 
diagnosed with irreversible pulpitis, pulpal anesthesia from the inferior 
alveolar nerve block is inadequate, and the pain is too severe for the 
endodontist to proceed. The success rate of supplemental intraosseous 
injection of 1.8 ml of 4% Articaine with 1:100,000 epinephrine is like the 
success rates of 82% to 91% reported for the supplemental intraosseous 
injection of 1.8 ml of 2% lidocaine with 1:100,000 epinephrine in the posterior 
mandible.  Thus, Articaine has proved to be a successful local anesthetic in all 
areas of dentistry including endodontics, periodontics, and exodontia and as 
well as supplementary injection.12, 56 
It should be aware that Articaine delivers nearly twice the 
concentration of active anesthetic to the patient; as compared to Lignocaine, 
thus one half of the amount should achieve similar anesthetic delivery. Due to 
a dense vascularization and innervation of the palatal mucosa, as well as, it's 
strong attachment to bone, palatal local anesthesia injections are frequently 
associated with at least some level of discomfort. With increased diffusion, 
Articaine can produce profuse pulpal as well as palatal anesthesia after 
maxillary buccal infiltrations, thus enabling the clinicians to avoid painful 
palatal infiltration. Shahid et al.55 found that Articaine can be used as an 
alternative to Lignocaine in the extraction of maxillary premolars for 
orthodontic reasons avoiding palatal injections that are painful. But              
AB Bataineh et al.3 found that buccal infiltration of 4% Articaine only is not 
adequate when manipulation of the palatal soft tissue is needed, and an extra 
palatal infiltration is recommended to produce pain-free extraction. 
There are differences between the anterior and posterior regions of the 
maxilla in innervation and bone quality. The anterior region of the maxilla has 
greater innervation density than the posterior region, which can affect the 
diffusion and anesthetic ability of Articaine when used as a buccal infiltration 
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for tooth extraction without a palatal injection. Different regions of the maxilla 
have different bone compositions. Age, gender, and race are factors that 
contribute to variation in bone composition of the maxilla. The anterior region 
of the maxilla has denser bone than the posterior region, which can affect the 
diffusion and anesthetic ability of Articaine when used as a buccal 
infiltration.3 Thus, the aim of the study is to evaluate the anesthetic efficacy of 
the Articaine in the surgical removal of the impacted maxillary canine tooth. 	
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AIMS AND OBJECTIVES 
 The purpose of the study was to evaluate the anesthetic efficacy of 4% 
Articaine with 1:100,000 epinephrine for surgical removal of impacted 
maxillary canine in terms of the following. 
 Time of onset 
 Pain  
 Duration of anesthesia 
 Hemodynamic changes after the administration of 4 % Articaine with 
1:100,000 adrenaline. 
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REVIEW OF LITERATURE 
            Kimmo Vahatalo et al (1993)
28
, conducted a study on Articaine and   
Lidocaine for Maxillary Infiltration Anaesthesia and concluded that infiltration 
of both 4% Articaine with 1:200,000 epinephrine and 2% Lidocaine with 
1:80,000 epinephrine produced adequate anesthesia in all subjects with no side 
effects and no statistically significant differences between these two local 
anaesthetics with respect to onset or duration of action. 
           Reinhard Oertel et al (1997)
52
, stated that Articaine is the most widely 
used  local anesthetic agent in dentistry in a number of European countries 
The amide structure of Articaine is similar to that of other local  anesthetics, 
but it contains an additional ester group which is quickly hydrolysed by 
esterase’s. Rapid sample preparation is critical in the accurate determination of 
Articaine serum concentrations, since blood and serum are the sites of 
metabolism. The time to maximum drug concentrations of Articaine occurs 
about 10 to 15 minutes after submucosal injection of Articaine 4% 80mg, 
irrespective of epinephrine (adrenaline). The mean maximum plasma drug 
concentration is about 400 μg/L for Articaine with epinephrine 1:200,000 and 
580 μg/L for Articaine without epinephrine. The elimination half-time of  
Articaine is about 20 minutes. Complete anesthesia can be observed in nearly  
90% of all cases, using Articaine 4% 60 to 80mg with epinephrine 1:200,000. 
Articaine is better able to diffuse through soft tissue and bone compared to 
other local anesthetics. The concentration of Articaine in the alveolus of a 
tooth in the upper jaw after extraction was about 100 times higher than that in 
the systemic circulation. The plasma protein binding rate of Articaine and 
articainic acid is 70%. It has been concluded that an unintentional 
intravascular injection of Articaine 80mg does not cause toxic effects in 
healthy individuals. 
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            Stanley F. Malamed et al (2001)
60
, Conducted a study to compare the 
safety and efficacy of Articaine (4 % with epinephrine 1:100,000) with that of 
Lidocaine (2 % with Epinephrine 1:100,000). A total of 1,325 subjects 
participated in these studies, 882 of whom received Articaine 4% with 
epinephrine 1:100,000 and 443 of whom received Lidocaine 2% with 
epinephrine 1:100,000. The overall incidence of adverse events in the 
combined studies were 22% for the Articaine group and 20% for the Lidocaine 
group. The most frequently reported adverse events in the Articaine group, 
excluding postprocedural dental pain, were headache 4%), facial edema, 
infection, gingivitis and paraesthesia (1% each). 
     Necdet Dogan et al (2003)
41
, Forty rats were used in this study. The 
rats  were randomly separated into 4 groups. Three groups were given 2%  
Lidocaine, 4% Articaine hydrochloride (AH), or injectable saline, and the 
fourth was a control group. Skin specimens underwent the breaking strength 
test (BST) and histologic examination at 1 week after the surgical procedure to 
examine the effect of Articaine hydrochloride on the healing of surgical 
wounds and to compare healing with that of Lidocaine. The author concluded 
that the study showed that Articaine hydrochloride is as safe a local anesthetic 
agent as Lidocaine from the standpoint of wound response. 
            Costa CG et al (2005)
11
, Twenty healthy patients randomly received 
1.8 mL of one of the three local anesthetics during operative dentistry 
procedures of low complexity on three maxillary posterior teeth to compare 
the onset and duration of pulpal anesthesia by maxillary infiltration using 2% 
Lidocaine with 1:100,000 epinephrine, 4% Articaine with 1:200,000 
epinephrine, and 4% Articaine with 1:100,000 epinephrine. The author  
concludes both Articaine solutions produced shorter onset and longer duration 
of pulpal anesthesia by maxillary infiltration than the use of the Lidocaine  
solution. Statistical analysis did not confirm better clinical results of 4% 
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Articaine with 1:100,000 epinephrine than with 4% Articaine with 1:200,000 
epinephrine. 
 Feck AS et al (2005)
15
, local anesthetic failures in dental patients can 
have many causes, including anatomical variations, technique and 
anxiety/fear. By understanding the mechanisms responsible for the failure of 
local anesthesia, patients can be treated more comfortably. Sedation in oral  
dentistry is highlighted as a way to reduce anxiety/fear and the patients 
perception of pain. Profound anesthesia can be accomplished more easily in 
relaxed patients with diminished or elevated anxiety /fear. 
            Mohammad Dib Kanaa et al (2005)
38
, conducted a study on 
Articaine and Lidocaine Mandibular Buccal Infiltration Anaesthesia and 
concluded that 4% Articaine with epinephrine was more effective than 2% 
Lidocaine with epinephrine in producing pulp anesthesia in lower molars after 
buccal infiltration (64.5% for Articaine and 38.7% for Lidocaine infiltrations). 
Both solutions produced mild discomfort during mandibular buccal 
infiltration.          
            Hersh Ev et al (2006)
22
, conducted a study on the pharmacokinetics 
and cardiovascular effects of high dose of 4% Articaine with 1:100,000 and 
1:200,00 epinephrine in maxillary right first molar infiltration, maxillary left 
first molar infiltration, maxillary right first premolar infiltration, maxillary left 
first premolar infiltration, right inferior alveolar nerve injection, left inferior 
alveolar nerve injection, right and left long buccal infiltrations and analysed 
venous blood samples of Articaine levels by non-invasive acoustic tonometry 
to measure a variety of cardiovascular parameters over a two hour period and 
stated that A200 is as safe as A100 and may be preferred in patients with 
cardiovascular disease and in those taking drugs that reportedly enhance the 
systemic effects of epinephrine. 
Review of Literature 
 
 
9 
 
            Jason Bigby et al (2006)
25
, conducted a study to determine the 
anesthetic efficacy and effect on heart rate of 4% Articaine with 1:100,000 
epinephrine for supplemental intraosseous injection in mandibular posterior 
teeth diagnosed with irreversible pulpitis. The results demonstrated that 
anesthetic success was obtained in 86% (32 of 37) of the patients. Maximum 
mean heart rate was increased by 32 beats/minute during the intraosseous 
injection. The authors have concluded that when the inferior alveolar nerve 
block fails to provide profound pulpal anesthesia, the intraosseous injection of 
4% Articaine with1:100,000 epinephrine would be successful 86% of the time 
in achieving pulpal anesthesia in mandibular posterior teeth of patients 
presenting with irreversible pulpitis. 
            Sina Uckan et al (2006)
59
, experiments to know whether Articaine 
HCl could provide palatal anesthesia in maxillary tooth removal  without the 
need for a second palatal injection. Results demonstrated permanent maxillary 
tooth removal with palatal injection (97.5%)and without palatal injection 
(96.8%) were compared the difference was not statistically significant (P _ 
.05). The author suggested permanent removal of maxillary teeth without 
palatal injection is possible by depositing 2 mL Articaine to the buccal 
vestibule of the tooth. 
           Alejandro Sierra Rebolledo et al (2007)
1
, conducted a randomized 
double-blind clinical trial with 30 patients programmed for the bilateral 
surgical  extraction of symmetrical lower third molars compared with 
anesthetic efficacy of 4% Articaine versus 2% Lidocaine in inferior alveolar 
nerve block during surgical extraction of impacted lower third molars. 
Statistically significant differences (p = 0.003) were observed in the mean 
duration of anaesthetic effect (220.86 min. for 4% Articaine vs. 168.20 min. 
for 2% Lidocaine). The author suggests that 4% Articaine offers better clinical 
performance than 2% Lidocaine, particularly in terms of latency and duration 
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of the anesthetic effect. However, the differences in anesthetic efficacy of the 
two solutions were not significant. 
          M. Anthony Pogrel (2007)33, reported that permanent nerve 
involvement following inferior alveolar nerve block may occur from 1 in 
20,000 to 850,000 patients with little information on local anesthetic used by 
the author. Patients with permanent nerve damage from blocks were recorded. 
Lidocaine was associated with 35 %, with Articaine causing approximately 30 
% of the cases. Nerve blocks may cause permanent damage to the nerves, 
independent of the local anesthetic used. The author concludes that Articaine 
is associated with this phenomenon in proportion to its usage. 
           Carlos F. Santos et al (2007)
9
, Fifty healthy volunteers underwent 
removal of symmetrically positioned lower third molars, in 2 separate 
appointments, under local anesthesia with either A100 or A200, in a double-
blind, randomized, and crossed manner to compare the use of 4% Articaine in 
association with 1:100,000 or 1:200,000 epinephrine in the lower third molar 
removal. The results demonstrated that A100 and A200 similar latency (1.64 
+/-  0.08 and 1.58 +/- 0.08 minutes, respectively; P >.05). The 2 solutions 
provided a similar duration of postoperative analgesia regardless of bone 
removal (around 200 minutes; P> .05). The 2 solutions also had a similar 
significant duration of anesthetic action on soft tissues (around 250 minutes; P 
>.05). The surgeon’s rating of intraoperative bleeding was considered very 
close to minimal. Transient changes in hemodynamic parameters were 
observed, but these were neither clinically significant nor attributable to the 
type of anesthetic used (P>.05). The authors conclude an epinephrine 
concentration of 1:100,000 or 1:200,000 in 4% Articaine solution does not 
affect the clinical efficacy of this local anesthetic. It is possible to successfully 
use the 4% Articaine formulation with a lower concentration of epinephrine 
(1:200,000) for lower third molar extraction with or without bone removal. 
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            Foster W et al (2007)
16, 
 conducted a study on 3 sets of injections – an 
inferior alveolar nerve block plus a mock buccal and a mock lingual 
infiltration of the mandibular first molar, an inferior alveolar nerve block plus 
a buccal infiltration and a mock lingual infiltration of the mandibular first 
molar in three separate appointments spaced at least one week apart. For the 
IANB plus mock buccal plus mock lingual infiltrations successful pulpal 
anaesthesia ranged from 53–74%. For IANB mock lingual plus buccal 
infiltration successful pulpal anaesthesia ranged from 57–69%. The success 
rate for the IANB for mock buccal plus lingual infiltration ranged from 54-
76% and concluded that adding a buccal or lingual infiltration of 1.8ml of    
2% Lidocaine with 1:100,000 epinephrine to and IANB did not significantly 
increase anaesthetic success. 
            Lacet-Lima et al
 
(2007)
29
, Evaluated the buccal vestibular - palatal 
diffusion of 4% Articaine with epinephrine 1:100,000  and 1:200,000 in 
maxillary impacted third molars without palatal injection on two hundred teeth 
and resulted the lack of necessity of supplemental palatal anaesthesia was 
1A(84%), 1B(98%), 2A(78%), 2B(82%). The author concluded that most of 
the extractions could be performed only with buccal vestibular anesthesia and 
vasoconstrictor concentration and the time interval between administration of 
the anesthetic and initiation of surgery did influence  buccal palatal diffusion. 
            Paul A. Moore et al (2007)
45
, conducted a study on Haemostatic and 
Anesthetic Efficacy of 4% Articaine HCl With 1:200,000 Epinephrine and 4% 
Articaine HCl With 1:100,000 Epinephrine When Administered Intraorally for 
Periodontal Surgery. Significant differences between the A100 and A200 
treatments were found for the surgeon’s ability to visualize the surgical field 
(rated as clear 83.3% of the time with A100 and 59.5% of the time with A200; 
P = 0.008), bleeding expectation (rated as equal to or better than expected 
85.7% of the time with A100 and 71.4% of the time with A200; P = 0.034), 
and volume of blood loss (54.9 +/- 36.0 ml for A100 and 70.2 +/- 53.0 ml for 
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A200; P = 0.018). Sixteen patients experienced 27 mild or moderate adverse 
events; the most common were postoperative pain (nine patients) and swelling 
(eight patients. The author observed that patients undergoing periodontal 
surgery, 4% Articaine anesthetic formulations containing epinephrine 
(1:100,000 or 1:200,000) provided excellent surgical pain control. For patients 
who can tolerate higher amounts of epinephrine, the 4% Articaine With 
1:100,000 epinephrine formulation had the additional therapeutic advantage of 
providing better visualization of the surgical field and less bleeding. 
           Andrew Haase et al (2008)
2
, conducted a study Comparing anesthetic 
efficacy of Articaine versus Lidocaine as a supplemental buccal infiltration of 
the mandibular first molar after an inferior alveolar nerve block found that 
mandibular buccal infiltration of the first molar after a standard IAN block, 4 
% Articaine with 1:100,000 epinephrine resulted in a higher success rate (88 
%) than 2 % Lidocaine with 1:100,000 epinephrine (71 % success rate). 
          Aurelia Alemany-Martínez et al (2008)
5
, prospective study was made 
of 80 normotensive individuals (40 females and 40 males, mean age, 27 years 
[range, 18 to 67 years]) for surgical extraction of the lower third molars to 
determine the hemodynamic changes in healthy patients during the surgical 
removal of lower third molars, and to evaluate whether these variations are 
attributable to patient anxiety and pain experienced during the surgical 
procedure. The results showed that the females have higher levels of anxiety.  
The most anxious patients had the lowest blood pressure value and the 
highest heart rate, although the differences did not reach statistical 
significance. The variations in blood pressure and heart rate during surgical 
extraction of the molars was within the normal limits. In the case of blood 
pressure, no significant changes were recorded; the highest mean systolic 
blood pressure and diastolic blood pressure values were observed at the time 
of ostectomy and/or tooth sectioning. The lowest heart rate values were 
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recorded at baseline, before the start of the surgical procedure, whereas the 
highest values were obtained during incision and flap raising. The oxygen 
saturation values showed no significant changes and were lower at the start of 
the surgical procedure. The authors observed most of the cardiovascular 
changes induced by surgical extraction of molars were within normal ranges, 
experienced due to the anxiety and stress induced by surgery.  
            IL Young Jung et al (2008)
23
, conducted a study on Evaluation of 
Buccal Infiltrations and Inferior Alveolar Nerve Blocks in Pulpal Anaesthesia 
for Mandibular First Molars they opined that buccal infiltration with 4% 
Articaine for mandibular first molars can be a useful alternative for clinicians 
since IANB has a faster onset and a similar success rate. 
           Jose -Lacet Lima-Junior et al (2008)
26
, Two hundred patients with 
age Group of 15-46 years was enrolled in a study comprising the evaluation of 
vestibular-palatal diffusion of 4% Articaine with epinephrine 1:100,000 and 
1:200,000, in impacted maxillary third molar extractions without palatal 
injection. The authors conclude that Articaine hydrochloride 4% with 
epinephrine 1:100,000 produces more effective buccal vestibule-palatal 
anesthesia than the 1:200,000 solution, when an interval of 10 minutes is 
allowed between the administration of the anesthetic and the initiation of 
surgery and also suggests that vasoconstrictor concentration may influence 
anesthetic diffusion. It may be that due to a slower absorption rate of the 
anesthetic with epinephrine 1:100,000 is available at a higher initial 
concentration for diffusion (forming a higher concentration gradient) than the 
1:200,000 solutions. Alternatively, the former may simply prolong in the 
vicinity of the neural fibres leading thus to a more efficient pain control. 
            M. D. Kanaa et al (2008)
31
, conducted a study on Articaine buccal 
Infiltration that enhances the effectiveness of Lidocaine inferior alveolar nerve 
block and concluded that inferior alveolar nerve block injection supplemented 
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with Articaine buccal infiltration was more successful than inferior alveolar 
nerve block alone for pulpal anesthesia in mandibular teeth. Articaine buccal 
infiltration or dummy buccal infiltration was more comfortable than IANB. 
 
          Vasconcellos RJ, Vasconcelos BC and Genu PR (2008)
64
, conducted 
a study to examine the effect of four different local anesthetics of the amide 
group (2% Lidocaine with 1:100.000 adrenaline; 3% Prilocaine with 0.30 IU 
felipressine; 2% Mepivacaine with 1:100.000 adrenaline; and 4% Articaine 
with 1:100.100 adrenaline) in patients undergoing extraction of lower third 
molars and verify the changes in systolic, diastolic and mean blood pressures, 
heart rate (HR) and oxygen saturation (SpO2). The results demonstrated 
increase in systolic blood pressure with Mepivacaine and Articaine; decrease 
in diastolic blood pressure with Lidocaine; increase in heart rate with all the 
anesthetics, but with no statistical significance in the case of Prilocaine. The 
variations in mean blood pressure and oxygen saturation were not statistically 
significant. All the hemodynamic changes returned to normal with no need for 
any further treatment. 
           Bahadir Ezmek et al (2010)
6
, conducted a study on Comparison of 
hemodynamic effects of Lidocaine, Prilocaine, and Mepivacaine solutions 
without vasoconstrictor in hypertensive patients. Sixty-five mandibular molars 
and premolars were extracted in 60 hypertensive patients. Inferior alveolar and 
buccal nerve blocks were performed with 2% Lidocaine hydrochloride (HCl), 
2% Prilocaine HCl or 3% Mepivacaine HCl without vasoconstrictor. And 
concluded Lidocaine, Prilocaine and Mepivacaine solutions without 
vasoconstrictor can be safely used in hypertensive patients. 
Gabriella A. Garisto et al (2010)
18
, conducted a study on the 
occurrence of paraesthesia after dental local anesthetic administration in the 
United States. The author concluded that paraesthesia arising from a local 
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anesthetic injection alone is a rare event. The findings show that the 4 % 
anesthetic solutions used in dentistry, namely Prilocaine, and Articaine, are 
more highly associated with the development of paraesthesia than are those of 
lower concentration. Therefore, dentists should consider these results when 
assessing the risks and benefits of using 4% local anesthetics for mandibular 
block anesthesia. 
           Daniel Torres-Lagares et al (2011)
13
, conducted a prospective, 
randomized, single-blinded, cross-over, controlled comparative study on 10 
patients with cardiovascular disease comparing cardiovascular effect of dental 
anaesthesia with Articaine (40 mg with epinephrine 0.5 mg % and 40 mg with 
epinephrine 1 mg%) versus Mepivacaine (30mg and 20 mg with epinephrine 1 
mg%). During the treatment period, the authors observed statistically 
significant differences as regards heart rate between injections with and 
without adrenalin (p< 0.039) and as regards systolic (p< 0.046) and diastolic 
(p < 0.046) blood the pressure during the stabilization period. In both cases, 
the parameters under study increase. Age, gender, jaw treated, treatment 
duration and the rest of cardiovascular variables did not affect the results and 
of the patients underwent ischemic alterations or any other complication 
derived from the treatment or the anesthesia. The authors conclude although 
no cardiac ischemic alterations or any other cardiovascular complications have 
been observed, and must be cautious with the administration of anesthetics 
containing vasoconstrictors in patients with cardiovascular diseases. 
           Matthew Martin et al (2011)36, conducted a study on Anesthetic 
Efficacy of 1.8 mL versus 3.6 mL of 4% Articaine with 1:100,000 
Epinephrine as a Primary Buccal Infiltration of the Mandibular First Molar 
and concluded that anesthetic efficacy of 3.6 mL 4% Articaine with 1:100,000 
epinephrine is better than 1.8 mL (higher success rate (70% vs 50%) of the 
same anesthetic solution in a primary mandibular buccal infiltration of the first 
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molar. However, the success rate of 70% is not high enough to support its use 
as a primary injection technique in the mandibular first molar extraction. 
            Shahid Hassan et al (2011)55, conducted a study on the Efficacy of 4% 
Articaine hydrochloride and 2% lignocaine hydrochloride in the extraction of 
maxillary premolars for orthodontic reasons and concluded that Articaine can 
be used as an alternative to lignocaine, especially in the extraction of   
maxillary premolars for orthodontic reasons. The clinical advantages including 
rapid onset, longer duration of action and greater diffusing property over 
lignocaine and the elimination of the need for a painful palatal injection were 
demonstrated. 
            P Arrow (2012)
43
, conducted a study on the comparison of Articaine 
4%and lignocaine 2% in block and infiltration analgesia in children and 
opined that there were a higher success and less painful treatment with inferior 
alveolar nerve block and there was no statistically significant difference in 
local analgesia success was observed, however Articaine and lignocaine when 
delivered via buccal infiltration. 
            Peer W. Kammerer, et al (2012)46, conducted a double-blind 
randomized clinical trial of anesthetic efficacy in comparison with 4% 
Articaine with epinephrine (1:100,000) and without epinephrine in inferior 
alveolar block for tooth extraction. Eighty-eight patients received inferior 
alveolar nerve blocks using 4% Articaine with 1:100,000 epinephrine (n = 41; 
group 1) or without epinephrine (n = 47; group 2) for extractions of  
mandibular teeth. In group 1, a significantly faster onset of the anesthetic 
effect (7.2 min vs. 9.2 min; P =.001) and a significantly longer duration of soft 
tissue anesthesia (3.8 h vs. 2.5 h; P =.0001) were observed.  The author 
minimize the epinephrine-induced side effects,  the author suggests 4% 
Articaine without epinephrine is a suitable anesthetic agent for dental 
extractions in the mandible after inferior alveolar nerve block anesthesia. 
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There may be less postoperative discomfort due to the shorter duration of 
anesthesia without increased postoperative pain. 
           Shruthi R et al (2013)
55
, conducted a study on Articaine for surgical 
removal of impacted third molar - a Comparison with Lignocaine. Results 
demonstrated the mean onset time of anesthesia in the study group was 2.07 +  
0.22 and 2.18 + 0.26 minutes in comparison group. A mean duration of 4.28 
+0.78 hours was seen with Articaine group and 3.51 + 0.45 hours with the 
lignocaine group and concluded that Articaine has similar efficacy as that of 
lignocaine with slightly longer duration and can be used as an alternative to 
lignocaine in third molar surgeries. 
            Eshagh Ali Saberi et al (2013)14, compared the Anaesthesia Efficacy of 
Articaine and Articaine plus Morphine for Buccal Infiltration in Mandibular 
Posterior Teeth with Irreversible Pulpitis and concluded that success rate of 
Articaine (68%), Articaine morphine (52%) and Lidocaine (64%). They stated 
no significant difference in the success rate between groups on self-reported 
pain response recorded on a VAS scale before and after local anesthetic 
injection during access preparation. 
           Hecio Henrique Araujo de Morais et al (2013)21, In a Clinical study 
evaluate hemodynamic changes with the use of 4% Articaine and 2 different 
concentrations of epinephrine (1:100,000 and 1:200,000) in the surgical 
removal of symmetrically positioned lower third molars. They concluded that 
4% Articaine solution influences hemodynamic parameters without 
perceptible clinical changes in healthy patients undergoing lower third molar 
removal. 
           M. K. Saggu et al (2014)32, the purpose of this study is to compare the 
efficacy of 4% Articaine with 1:100,000 adrenaline (4AA) with that of 2% 
Lidocaine with 1:100,000 adrenaline (2LA) administered as buccal 
infiltrations for anesthesia in mandibular permanent first molar teeth. Results  
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demonstrate the relative efficacy of 4AA over 2LA in anesthetizing permanent 
first mandibular molars were calculated at 1.57 and conclude that 4AA has 
been shown to have greater efficacy in achieving pulpal anesthesia  in 
mandibular permanent first molar teeth than 2LA when administered via 
buccal infiltration. 
            Anwar B. Bataineh et al (2016)
3
, conducted a prospective controlled 
study with Forty-eight patients who needed routine extraction of permanent 
maxillary teeth without a palatal injection in comparison Between the Anterior 
and posterior regions of the maxilla. They found that Extraction of maxillary 
teeth were possible without an additional palatal injection for 87 teeth 90.6%), 
whereas only 9 teeth (9.4%) needed an additional palatal injection to complete 
the extraction. Of the total number of patients, 90% reported to have pain 
caused by tooth extraction in the anterior and posterior regions of the maxilla 
were mild. There was no difference in pain perception when extracting 
anterior and posterior teeth. Of the total number of teeth, 90.6% were 
extracted without the need for palatal injection. Extraction of erupted 
maxillary teeth using 4% Articaine without manipulation of the palatal mucosa 
obviated palatal infiltration during extraction. Articaine anesthesia  provides 
adequate palatal anesthesia for maxillary teeth extraction in the anterior and 
posterior regions without the need for a palatal block. 
           G. Bartlett et al (2016)
17
, conducted a study on Articaine buccal 
infiltration vs Lidocaine inferior dental block – a review of the literature. 
Results demonstrated   that 55.6–69.2% and 65.4–70.4% of Lidocaine inferior 
alveolar nerve block and Articaine buccal infiltrations were successful, and 
opined that Articaine buccal infiltrations are no more effective than Lidocaine 
inferior alveolar nerve block. 
           Uros Marjanovic et al (2017)37, conducted a study on two different 
techniques of local anesthesia in the posterior mandible using 4% Articaine 
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with 1: 100,000 adrenaline. 60 patients participated in the study, aged between 
18 to 50 years were divided into two groups of 30 participants each – the local 
infiltration anesthesia group, with participants who received the local 
infiltration anesthesia in the projection of roots apices of the first lower molar 
and the inferior alveolar nerve block group with participants who received the 
regular IAN block. The onset of anesthesia determined by loss of sensation, 
changes in teeth sensitivity determined by the electric pulp test, duration of 
anesthesia, width of the anesthetic field and possible changes of 
cardiovascular parameters (systolic and diastolic blood pressure and heart rate) 
and concluded  that the effect of the local infiltration anesthesia on tooth 
sensitivity of premolars and first molar were quite satisfactory the inferior 
alveolar nerve block was more effective for the canine and second molar. 
None of the tested techniques had any significant effect on the cardiovascular 
parameters. 
            Astha Jaikaria et al (2018)
4
, A total of 102 patients were randomly 
selected for the study who required maxillary molar extractions and received 
buccal infiltration either using Lidocaine or Articaine to compare and evaluate 
the efficacy of 4% Articaine and 2% Lidocaine in children in the primary  
maxillary molar extractions. For subjective evaluation, the Wong Baker Facial 
Pain Scale (FPS) was used. For objective evaluation, the FLACC Scale was 
used. As hemodynamic parameters of heart rate and blood pressure recordings 
are physiological indicators of pain response, they were recorded using a 
sphygmomanometer. The authors informed that Articaine is effective as a 
local anesthetic and can be used as an alternative to Lidocaine in pediatric 
patients. Lower mean values for FPS and stable hemodynamic parameters 
during infiltration make Articaine a likely choice as an anesthetic in paediatric 
patients. 
           Jyoti Mitta et al (2018)
27
, conducted a comparative study on the 
efficacy of 4% Articaine vs 2% Lidocaine in surgical removal of bilaterally 
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impacted mandibular third molars. Results indicated that 4% Articaine was 
found to have a significantly shorter onset of action than 2% Lidocaine. 
Duration of anesthesia and postoperative analgesia of 4% Articaine with 
epinephrine 1:200,000 was found to be significantly (1.44 and 1.28 times 
respectively) longer than 2% Lidocaine with epinephrine 1:200,000. There 
was no significant difference recorded in the anesthetic efficacy between the 
two solutions. 
           Mohammed Sulaiman Alsale et al (2018)
39
, conducted a comparative 
study on the hemodynamic effects of local anaesthetics Articaine vs. 
Lidocaine in healthy patients and they observed are no significant differences 
in any of the hemodynamic parameters were observed at any stage of the 
investigations when the patients have injected with 4% Articaine with 
1/100,000 epinephrine and 2% Lidocaine with 1:100,000 epinephrine.       
            Myong-Hwan Karm et al (2018)
40
, conducted a study on Rats and 
mice were randomly allocated to experimental groups: 2% Lidocaine without 
epinephrine (L0), 2% Lidocaine with epinephrine 1:200,000 (L200), 
1:100,000 (L100), and 1:80,000 (L80). Changes in mean arterial pressure and 
heart rate after administration of the anesthetic mixture. The author concluded 
that the L100 and L80 local anesthetic mixtures containing a higher 
concentration of epinephrine showed unfavourable hemodynamic changes 
including increases in MAP and HR. L0, plain Lidocaine, had a short duration 
of anesthetic action. L200 demonstrated relatively stable mean arterial 
pressure and heart rate values with satisfactory action duration and hemostatic 
effect. 
          Nikil Kumar Jain et al (2018)
42
, conducted a study on Anesthetic 
efficacy of 4% Articaine versus 2% lignocaine during the surgical removal of 
the third molar and concluded that Articaine had a significantly faster onset of 
action and longer duration of action when compared to lignocaine, the pain 
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experienced by the patients during and after the surgical procedure was 
significantly less.  
           Paramjot Kaur et al (2018)
44
, investigated and compare the response 
of lignocaine with and without epinephrine to evaluate hemodynamic and 
metabolic response in normotensive and type II controlled diabetic patients  
(hemodynamic and glycaemic response) undergoing tooth extractions. A total 
of 50 patients (25 healthy and 25 controlled type II diabetics) undergoing 
multiple tooth extractions (of the age group of 20–80 years). Results 
demonstrated the increase in blood glucose concentration following the 
administration of 2% lignocaine HCl with 1:200,000 epinephrine was 
statistically significant (P < 0.05). Statistically significant variability in 
diastolic BP (diastolic blood pressures) was also noted in controlled diabetic 
patients. Both systolic blood pressure and diastolic blood pressures were 
statistically significantly elevated after the administration of 2% lignocaine 
HCl. The author concluded that 2% lignocaine HCl with 1:200,000 
epinephrine in type II diabetics could be safely used and 2% lignocaine HCl 
should be used with caution in normotensive as well as type II controlled 
diabetic patients. 
            Sunith Maruthingal et al (2018)
62
, conducted a study on A 
comparative evaluation of 4% Articaine and 2% Lidocaine in mandibular 
buccal infiltration Anesthesia and concluded that Articaine showed significant 
results within achieving pulpal anesthesia objectively, when compared with 
Lidocaine and also showed very highly significant results subjectively in 
achieving lip numbness, when compared to Lidocaine. But the results in 
achieving lingual mucosa numbness with Articaine subjectively was not 
significant, when compared with Lidocaine. 
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MATERIALS AND METHODS 
This study was conducted in the Department of Oral and Maxillofacial 
Surgery, Ragas Dental College and Hospital, Chennai. All the patients 
scheduled for surgical removal of impacted maxillary canine were explained 
about the study and the patients willing to participate were included in the 
study. The patients were randomly allotted to either group A (Articaine) or 
group B (Lidocaine). In all the patients buccal and palatal infiltration was 
given to administer local anaesthesia. Ethical clearance was obtained from The 
Institutional Review Board prior to commencing the study. A written informed 
consent was obtained from all the patients for both surgical procedure and 
radiological investigations prior to the procedure. 
 
INCLUSION AND EXCLUSION CRITERIA 
INCLUSION CRITERIA: 
1. All patients requiring surgical removal of Impacted Maxillary Canines.  
2. Age group between 18-48 years. 
3. Both sexes to be included. 
EXCLUSION CRITERIA: 
1. Known or suspected allergies or sensitivities to amide-type local 
anesthetics or any ingredients in the anesthetic solution. 
2. Medical history of any systemic disease like- Hypertension, Diabetes, 
Thyroid disorders, Liver diseases, Renal diseases, bleeding & clotting 
disorders etc. 
3. Pregnancy or lactation. 
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4. Subjects who are under anti-depressants and sedatives. 
5. Subjects who had taken analgesic medication 24 hours prior to 
administration of local anesthesia. 
6. Patients with any local pathological conditions that can influence the 
local anesthetic action like infection, bony exostosis etc. 
SURGICAL PHASE 
ARMAMENTARIUM USED: -  
1. 4% Articaine HCL with 1:100,000 Adrenaline (SEPTANEST; 
SEPTODONT Inc, FRANCE). 
2. 2% Lidocaine HCL with 1:80,000 Adrenaline (LIGNOSPAN; 
SEPTODONT Inc, FRANCE). 
3. Aspirating dental injection syringe. (SEPTODONT FUSION; U.S.A). 
4. Sterile, siliconized, disposable needles 27 Gauge, 0.40 x 35mm. 
5. Pulse oximeter (OXYWATCH; choice Med, Beijing, CHINA),  
6. Automated Blood Pressure Monitor (OMRON; OMRON 
HEALTHCARE CO., LTD, VIETNAM). 
7. No 15-Bard-Parker blade & handle with No 3 handle. 
8. Molt no 9 Periosteal elevator. 
9. Howards Periosteal elevator. 
10. Austin Retractor. 
11. Adson tissue forceps. 
12. Micro motor straight handpiece with 702 straight bur. 
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13. Elevators. 
14. Needle Holder. 
15. Bone file. 
16. Bone Curette. 
17. Frazier Suction tip. 
18. Heath scissors. 
19. 3-0 silk suture material. 
SURGICAL TECHNIQUE: - 
All patients were positioned at a semi-reclined position on the dental 
chair. Patients were prepared and draped. The surgical site was irrigated with 
saline and hexedine mouthwash was given. 4% Articaine was injected in the 
buccal and palatal mucosa (infiltration) over a period of 1 minute for Group A 
and 2% Lidocaine was injected in the buccal and palatal mucosa (infiltration) 
over a period of 1 minute for Group B. 
The patient was asked to inform when they feel the numbness and then  
the buccal and the palatal mucosa was examined using pinprick test. Surgical 
access is achieved by either buccal approach or palatal approach or both 
depending on the type of impaction. Mucoperiosteal flap was elevated and 
bone guttering was carried out with 702 surgical bur with continuous irrigation 
with saline and the impacted canine tooth was exposed. 
 Tooth sectioning was done when needed and the impacted canine 
tooth was extracted. Wound toileting was done and hemostasis achieved.  The 
wound was closed with 3-0 silk and sutures were removed after a week.  
The patients were instructed to eat only soft food and abstain from 
forceful mouth washing for the first 24h. For postoperative pain control, all 
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patients received Ketorolac Tromethamine 10mg which was administered 
twice daily, 500mg amoxicillin was prescribed every 8hourly (TID) for 5days 
to prevent infection.  
For plaque control, the patient used 0.12% chlorhexidine mouth rinse 
for one minute twice a day for two weeks postoperatively. 
EVALUATION CRITERIA: - 
1. Drug volume: - Amount of anesthetic used in each case and any 
additional injections required were recorded. 
2. The onset of anesthesia: - Time of onset of anesthesia is calculated  
form the time elapsed from full needle withdrawal after injection  
until the patient first reports numbness and immediately checked  
for objective signs. 
3. Duration of surgical procedure: - From the time of incision placed 
to the last suture placed. 
4. Duration of anesthesia: - Duration of anesthesia is calculated by 
recording the time from initial patient perception of the anesthetic 
effect to the moment in which the effect began to fade. 
5. Blood pressure, oxygen saturation and heart rate were recorded  
before the administration of local anesthesia and after 5,15,30,45  
and 60 minutes. 
6. Signs of systemic toxicity: - Talkativeness, slurred speech,  
apprehension, localized muscle twitching, and post-operative  
complications like paresthesia and others were noted. 
7. Pain rating based on VAS score: The VAS was taken by a different 
operator to avoid influencing the patient during scoring. 
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VISUAL ANALOG SCALE 
              Intra operative pain was scored on visual analog scale (0–10) at  
15minutes and 30 minutes (e.g. none, slight, mild, moderate, severe). 
 
0 No Pain The patient feels well 
1-2 Mild pain If the patient is distracted he or she does not feel pain 
3-4 Moderate pain The patient feels light pain but not disturbing the procedure 
5-6 Severe pain 
The patient feels pain but was able to tolerate the 
procedure. 
7-8 Very severe pain 
The patient feels more pain and forces to abandon the 
procedure. 
9-10 
Worst possible 
pain 
The procedure and every type of activity must be 
abandoned and patient needs medical attention. 
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RAGAS DENTAL COLLEGE & HOSPITAL 
DEPARTMENT OF ORAL AND MAXILLOFACIAL SURGERY 
IMPACTION CASE SHEET 
 
OP.NO:                                                                                                     DATE:                                                        
AGE/SEX: 
NAME:                                                                                                   
OCCUPATION:                                                                                     
ADDRESS:                                                                                             
CHIEF COMPLAINT: 
HISTORY OF PRESENT ILLNESS: 
PAST MEDICAL HISTORY: 
  HYPERTENSION 
  ASTHMA 
  TUBERCULOSIS 
  DRUG ALLERY 
  BLEEDING DISORDERS 
  CARDIOVASCULAR SYSTEM 
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ANEMIA 
                PREVIOUS HISTORY 
                PRESENTLY ANAEMIC? 
OTHERS: 
 
PAST DENTAL HISTORY: 
 
PERSONAL HISTORY: 
 
CLINICAL EVALUATION: ERUPTED / PARTIALLY ERUPTED / NON-
ERUPTED: 
 
INTERPRETATION OF RADIGRAPH/CBCT: 
 
CLASSIFICATION: 
 
EVALUATION: 
 
DRUG VOLUME: (ARTICAINE/LIGNOCAINE):  
 
ONSET OF ANAESTHESIA: 
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DURATION OF SURGICAL PROCEDURE: 
 
DURATION OF ANAESTHESIA: 
 
HEMODYNAIMICS-  
VITALS BEFORE 
L. A 
15 
MINUTES 
30 
MINUTES 
45MINUTES 60 
MINUTES 
BLOOD 
PRESSURE 
     
OXYGEN 
SATURATION 
     
HEART RATE      
 
 
PAIN RATING BASED ON VAS SCORE: 
            Intra operatively pain was scored on visual analogue scale (0–10) at 
15minutes and 30 minutes (e.g. none, slight, mild, moderate, severe). 
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PROCEDURE: 
 
 
 
POSTOPERATIVE MEDICATION: 
 
 
 
POSTOPERATIVE REVIEW: 
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Figures 
 
 
Fig.1 ASPIRATING DENTAL INJECTION SYRINGE                       
(SEPTODONT FUSION; U.S.A). 
 
 
 
Fig.2 STERILE, SILICONIZED, DISPOSABLE NEEDLES                         
27 GAUZE, 0.40 x 35mm (Gauge & length in mm). 
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Fig.3 4% ARTICAINE HCL WITH 1:100,000 ADRENALINE 
(SEPTANEST; SEPTODONT Inc, FRANCE). 
 
 
Fig.4 2% LIDOCAINE HCL WITH 1:80,000 ADRENALINE (LIGNOSPAN; 
SEPTODONT Inc, FRAN CE). 
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Fig.5 AUTOMATED BLOOD PRESSURE MONITOR (OMRON; 
OMRON HEALTH CARE CO., LTD, VIETNAM). 
 
 
Fig.6 PULSE OXIMETER (OXYWATCH; choice Med, Beijing, CHINA), 
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Fig.7 ARMAMENTARIUM 
 
 
 
Fig.8 MICROMOTOR & HANDPIECE 
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Fig.9 CASE-1 PRE-OPERATIVE CBCT  
(LABIALLY POSITIONED CANINE) 
 
Fig.10 PRE-OPERATIVE OCCLUSAL RADIOGRAPH 
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Fig.11 CREVICULAR INCISION 
 
 
Fig.12 MUCOPERIOSTEAL FLAP ELEVATION 
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Fig.13 BONE GUTTERING 
 
Fig.14 EXPOSURE OF IMPACTED CANINE 
 
Figures 
 
 
Fig.15 TOOTH SECTIONING 
 
Fig.16 CROWN REMOVAL 
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Fig.17 ROOT REMOVAL 
 
Fig.18 EXTRACTED CANINE 
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Fig.19 APPROXIMATION OF FLAPS AND SUTURING 
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Fig.20 CASE-2 PRE-OPERATIVE CBCT 
 (PALATALLY POSITIONED CANINE) 
 
Fig.21 PRE-OPERATIVE OPG 
 
Figures 
 
 
Fig.22 MUCOPERIOSTEAL FLAP ELEVATION 
 
Fig.23 EXPOSURE OF IMPACTED CANINE 
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Fig.24 CROWN & ROOT REMOVAL 
 
Fig.25 EXTRACTED CANINE 
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Fig.26 APPROXIMATION OF FLAPS AND SUTURING 
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PHARMACOLOGY OF ARTICAINE HCL 
Classification: It belongs to amide group of local anaesthetics. 
Chemical formula: 3-N-propylamino-propionylamino-2 carbomethoxy – 4 – 
methyl thiophene hydrochloride. Articaine differs from the previous amide 
local anaesthetics in that it has a thiophene ring in its molecule instead of the 
usual benzene ring.  The thiophene ring within its structure renders Articaine 
more lipid-soluble. This allows more anaesthetic to diffuse across the nerve 
membrane, increasing its potency.52 	
 
Prepared by: H.Rusching et al, 1969 
FDA approved: April 2000 
Introduced: 1976 in Germany and Switzerland, 1983 in Canada, 2000 in U.S 
Potency: 1.5 times that of Lidocaine and 1.9 times that of Procaine 
Toxicity: similar to Lidocaine and Procaine 
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Mechanism of action: 
 Action of Articaine is like other local Anesthetics in reversibly 
blocking nerve conduction. Articaine blocks nerve conduction by reversibly 
binding to the α-subunit of the voltage-gated sodium channels within the inner 
cavity of the nerve, similar to other local anaesthetics. Binding of Articaine to 
the sodium channel reduces sodium influx so that the threshold potential will 
not be reached, and impulse conduction stops. The blocking action of 
Articaine on the sodium channel is state dependent: it has the highest affinity 
for the open state, an intermediate affinity for the inactivated state, and the 
lowest affinity for the resting state. The degree of neuronal block is affected 
by the diameter of the nerve. Articaine is lipid soluble, highly protein-bound 
(94%), and has a dissociation constant (pKa) of 7.8. pH with vasoconstrictor is 
3.5 to 4.0.52 
Effective dental concentration: 4% with 1:100,000 or 1:200,000. 
Onset Of Action:  
           Articaine 1:200,000 - infiltration 1 -2 mins, mandibular block 2-3 mins. 
Articaine - 1:100,000 infiltration 1-2 mins, mandibular block 2 – 2 1/2 mins. 
Duration of action:  
           The formulation with 1:100,000 epinephrine provides between 60 and 
75 minutes of pulpal anaesthesia; the 1:200,000 formulation, approximately       
45 to 60 minutes.  
Anaesthetic half-life: 0.5 hours 
Topical anaesthetic action: Not in a clinically acceptable concentration  
Pregnancy classification: Unknown 
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Safety during lactation: Unknown 
Metabolism: 
            Articaine differs from the other amide local anesthetics because it 
contains a thiophene ring and Articaine contains an ester group also, 
biotransformation occurs in both plasma (hydrolysis by plasma esterase) and 
liver (hepatic microsomal enzymes). Degradation of  Articaine HCL is 
initiated by hydrolysis of the carboxylic acid ester groups to give free 
carboxylic acid. It's primary metabolite, articainic acid, is pharmacologically 
inactive, undergoing additional biotransformation to form articainic acid 
glucuronide.60 
Excretion:  
           The renal clearance of Articaine is 1.35 +/- 0.83 L/h, whereas that of 
articainic acid is 7.18 +/= 1.81 L/h. Articainic acid glucuronide is not present 
in plasma. These results suggest that articainic acid is glucuronidated by the 
tubular cells and then excreted via kidneys approximately 5% to 10% 
unchanged, and 90% metabolites. The metabolite articainic acid shows a half-
life of 2 to 2.5 hours. The total recovery of the dose in the urine varies 
between 50 and 92% over 36 hours.60 
Vasodilating properties: 
Articaine, like most local anesthetics at concentrations that are used 
clinically, has a vasodilatory effect, increasing its systemic absorption. Its  
vasodilation effect is equal to Lidocaine. Procaine is slightly more vasoactive. 
This is countered in preparations with epinephrine 1:100,000, and 1:200,000. 
The distribution of the drug is influenced by the degree of tissue and plasma 
protein binding of the drug. The more protein-bound the agent, the longer the 
duration of action, as the free drug is more slowly made available for 
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metabolism. Based on its physiochemical and stereochemical properties, 
protein binding of Articaine is 94%.61 
Maximum dose:  
Recommendations regarding maximum doses of local anesthetics lack 
scientific justification; therefore, the recommended highest dose of Articaine, 
assumed to be around 4–7 mg/kg (7.0mg/kg or 3.2mg/lb.), must be interpreted 
as an important guide number.60 
Neurotoxicity: 
All commonly used local anesthetics produce neurotoxicity in a 
concentration-dependent manner. Proposed causes for neurological deficits are 
neural ischemia (due to local vasoconstriction caused by the local anesthetic 
itself or by epinephrine) or inflammation. Clinical signs are perioral and 
tongue paresthesia, a metallic taste, and dizziness passing into slurred speech, 
diplopia, tinnitus, confusion, restlessness, and muscle twitching progressing to 
neuronal depression and leading to convulsions and coma. The severity of 
cardiovascular and central nervous system toxicity is directly related to the 
local anesthetic potency, dose, and rate of administration. In this context, one 
must distinguish acute toxicity caused by accidental intravascular 
administration from toxicity caused by the systemically absorbed local 
anesthetic. Patients with hepatic or renal impairment both metabolites can 
accumulate, which in theory can cause local anesthetic systemic toxicity 
(LAST). The American Society of Regional Anesthesia and Pain Medicine 
advises that heightened vigilance may be warranted in these patients 
particularly if they are at the extremes of age.60 
 
   Pharmacology 
 
35 
 
 
Contraindications: 
            Articaine is contraindicated in patients allergic to amide type 
anesthetics and patients allergic to metabisulfites (preservative present in the 
formula to extend the life of epinephrine), as there is no cross	 allergenicity 
between sulfites (preservatives), sulphur, and the “sulpha” -type antibiotics. It 
is contraindicated in patients with hemoglobinopathies (sickle cell disease) 
and in patients with idiopathic or congenital methemoglobinemia, but 
methemoglobinemia is not a concern in the dental practice due to the small 
volumes of Articaine used. Articaine is not contraindicated in patients with 
sulpha allergies; there is no cross allergenicity between arcticain’s Sulphur 
bearing thiophene ring and sulphonamides.35 
          In children 4–13 years of age, the only adverse event directly related to 
Articaine was accidental lip injury; no pharmacokinetic investigation was 
performed. Prolonged numbness appears to be the most frequent adverse event 
after Articaine for dental intervention, occurring primarily in children younger 
than 7 years old. Notwithstanding manufacturers' recommendations that 
Articaine not be used in children under 7 years of age. 16 
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RESULTS 
  This study was performed in Ragas Dental College and Hospital in the 
Department of Oral and Maxillofacial surgery during the period of January 
2017 to June 2018. The study was designed to evaluate the clinical efficacy of 
4% Articaine with 1:100,000 epinephrine for surgical removal of impacted 
maxillary canines. Data obtained was entered in excel sheet and analyzed 
using SPSS v20. Significance was set at p<0.005. Since the data was found to 
follow non-normal distribution, non-parametric test (Mann Whitney u test) 
was used to test quantitative variables and chi square test was used to test 
qualitative variables. 
Age and Sex Distribution  
 A total of twenty Patients were included in the study, five male (50%) 
and five female (50%) patients with mean age of 30.20 years (SD: 9.12) were 
allocated to Group A (Table.1). Four male (40%) and six female (60%) 
patients with mean age of 29.30 years (SD: 8.42) were allocated to Group B 
(Table.2).  Statistically no significant difference was seen in mean age           
(p = 0.761) & distribution of males and females (p = 0.500) between the two 
groups.  
Drug Volume  
 The mean drug volume was 1.9ml (SD: 0.2) for Group A and 2.2 ml 
(SD: 0.5) for Group B (Table.3), there was no statistically significant 
differences between the two groups (p > .50067). 
 
 
 
 Results 
 
37 
 
Pain Score 
 The subjective intraoperative pain scoring by the patients showed no 
differences between the two anesthetic solutions, (p > 0.639 at 15minutes and 
p > 0.135 at 30 minutes interval) for Group A and Group B (Table.4, Table.5). 
Duration of Procedure  
 The mean duration of procedure was 39.00 min (SD: 5) for Group A 
and 42.00 min (SD: 4.5) for Group B (Table.3), there was no statistically 
significant differences between the two groups (p = 0.202). 
Onset of Anaesthesia  
 The mean onset of Anaesthesia was 42 seconds (SD: 7) for Group A 
and 60 sec (SD: 4) for Group B (Table.3), there was statistically significant 
differences between the two groups (p < 0.005 = 0.000). 
Duration of Anaesthesia  
 The mean duration of Anaesthesia was 120.00 min (SD: 14) for Group 
A and 91.00 min (SD: 10) for Group B (Table.3), there was statistically 
significant differences between the two groups (p < 0.005 = 0.001). 
Hemodynamics 
 With respect to the hemodynamics parameters, there was no 
statistically significant difference in blood pressure (Table.9) (Table.10) 
(Table.11), heart rate (Table.6), or oxygen saturation (Table.7) (Table.8) 
before and during the surgery   (p > 0.05). 
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Table.1 AGE OF THE PARTICIPANTS 
 
AGE (Years) 
ARTICAINE 
(Group A) 
Mean 30.2000 
Std. Deviation 9.12627 
LIDOCAINE 
(Group B) 
Mean 29.3000 
Std. Deviation 8.42021 
 
 
 
Table.2 GENDER OF THE PARTICIPANTS 
 
GROUP Frequency Percent 
ARTICAINE 
(Group A) 
MALE 5 50.0 
FEMALE 5 50.0 
LIDOCAINE 
(Group B) 
MALE 4 40.0 
FEMALE 6 60.0 
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Table.3 DRUG VOLUME, ONSET OF ANAESTHESIA, DURATION 
OF PROCEDURE & DURATION OF ANAESTHESIA 
 
 
Table.4 PAIN SCORE AT 15 MINS 
(Visual Analog Scale) 
 No Pain Mild Pain p- VALUE 
GROUP 
ARTICAINE 
(Group A) 
7 3  
LIDOCAINE 
(Group B) 
6 4 .639 
GROUP 
DRUG 
VOLUME 
(ml) 
ONSET OF 
ANAESTHESIA 
(Seconds) 
DURATION 
OF 
PROCEDURE 
(Minutes) 
DURATION OF 
ANAESTHESIA 
(Minutes) 
ARTICAINE 
(Group A) 
Mean 1.8600 42.2000 39.5000 120.8000 
Median 1.8000 41.0000 40.0000 125.0000 
Mode 1.80 36.00 40.00 100.00 
Std. Deviation .18974 7.33030 5.50252 14.58157 
LIDOCAINE 
(Group B) 
Mean 2.1800 60.0000 42.0000 91.8000 
Median 1.8000 59.5000 45.0000 91.0000 
Mode 1.80 54.00a 45.00 90.00 
Std. Deviation .50067 4.08248 4.83046 10.72691 
 p- VALUE .091 0.000 .202 0.001 
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Table.5 PAIN SCORE AT 30 MINS 
(Visual Analog Scale) 
 No Pain Mild Pain P - Value 
GROUP 
ARTICAINE 
(Group A) 
4 6  
LIDOCAINE 
(Group B) 
4 6 0.135 
 
 
Table.6 HEART RATE (HR) 
 
 
GROUP 
HR 
BEFORE 
LA 
HR AT 
15 MIN 
HR AT 
30 MIN 
HR AT 
45 MIN 
HR AT 60 
MIN 
ARTICAINE 
(Group A) 
Mean 76.0000 81.5000 74.8000 73.4000 74.4000 
Median 76.0000 80.0000 73.0000 70.0000 74.0000 
Mode 78.00 66.00 66.00 68.00 72.00 
Std. 
Deviation 8.90693 
10.2333
9 8.59974 6.25744 8.31598 
LIDOCAINE 
(Group B) 
Mean 77.5000 83.3000 74.5000 75.0000 76.8000 
Median 78.0000 83.0000 74.0000 75.0000 78.0000 
Mode 78.00 84.00 78.00 70.00 80.00 
Std. 
Deviation 5.58271 6.63409 3.37474 5.43650 5.18116 
 p- VALUE 
 .648 .543 .647 .396 .491 
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Table.7 OXYGEN SATURATION (OS) 
 
 
GROUP 
OS 
BEFORE 
LA (%) 
OS AT 15 
MIN (%) 
OS AT 30 
MIN (%) 
OS AT 
45 MIN 
(%) 
OS AT 
60 MIN 
(%) 
ARTICAINE 
(Group A) 
Mean 98.9000 96.7000 98.4000 98.5000 99.1000 
Median 99.0000 96.0000 98.5000 98.0000 99.0000 
Mode 99.00 96.00 99.00 98.00 100.00 
Std. 
Deviation .73786 1.25167 .96609 .70711 .87560 
LIDOCAINE 
(Group B) 
Mean 98.8000 97.2000 98.7000 98.9000 99.3000 
Median 99.0000 97.5000 99.0000 99.0000 99.5000 
Mode 99.00 99.00 99.00 99.00 100.00 
Std. 
Deviation 
.91894 2.20101 .82327 .99443 .82327 
 P - 
VALUE 
.902 .640 .438 .245 .598 
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Table.8 MEAN RANKS FOR HEART RATE & OXYGEN 
SATURATION 
 
RANKS 
 GROUP N Mean Rank Sum of Ranks 
HR BEFORE 
LA 
ARTICAINE 10 9.90 99.00 
LIDOCAINE 10 11.10 111.00 
Total 20   
HR AT 15 
MIN 
ARTICAINE 10 9.70 97.00 
LIDOCAINE 10 11.30 113.00 
Total 20   
HR AT 30 
MIN 
ARTICAINE 10 9.90 99.00 
LIDOCAINE 10 11.10 111.00 
Total 20   
HR AT 45 
MIN 
ARTICAINE 10 9.40 94.00 
LIDOCAINE 10 11.60 116.00 
Total 20   
HR AT 60 
MIN 
ARTICAINE 10 9.60 96.00 
LIDOCAINE 10 11.40 114.00 
Total 20   
OS BEFORE 
LA 
ARTICAINE 10 10.65 106.50 
LIDOCAINE 10 10.35 103.50 
Total 20   
OS AT 15 
MIN 
ARTICAINE 10 9.90 99.00 
LIDOCAINE 10 11.10 111.00 
Total 20   
OS AT 30 
MIN 
ARTICAINE 10 9.55 95.50 
LIDOCAINE 10 11.45 114.50 
Total 20   
OS AT 45 
MIN 
ARTICAINE 10 9.05 90.50 
LIDOCAINE 10 11.95 119.50 
Total 20   
OS AT 60 
MIN 
ARTICAINE 10 9.85 98.50 
LIDOCAINE 10 11.15 111.50 
Total 20   
 
 
Tables and Graphs 
 
  
Table.9 SYSTOLIC BLOOD PRESSURE (SYSTOLIC BP IN mmHg) 
 
 
GROUP 
SYSTOLIC 
BP 
BEFORE 
LA 
SYSTOLIC 
BP AT 15 
MIN 
SYSTOLIC 
BP AT 30 
MIN 
SYSTOLIC 
BP AT 45 
MIN 
SYSTOLIC 
BP AT 60 
MIN 
ARTICAINE 
(Group A) 
Mean 116.6000 130.4000 118.6000 115.6000 118.4000 
Median 115.0000 132.0000 119.0000 119.0000 120.0000 
Mode 110.00 128.00 110.00 100.00 120.00 
Std. 
Deviation 
10.06865 13.29327 10.24370 10.27619 6.31049 
LIDOCAINE 
(Group B) 
Mean 121.0000 129.4000 117.8000 112.8000 117.8000 
Median 118.0000 124.0000 114.0000 110.0000 116.0000 
Mode 118.00 124.00 110.00 110.00 110.00 
Std. 
Deviation 
10.50926 10.83410 9.68160 7.43565 8.66410 
 
P - 
VALUE 
.402 .820 .878 .418 .728 
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Table.10 DIASTOLIC BLOOD PRESSURE                              
(DIASTOLIC BP IN mmHg) 
 
 
GROUP 
DIASTOLIC 
BP BEFORE 
LA 
DIASTOLIC 
BP AT 15 
MIN 
DIASTOLIC 
BP AT 30 
MIN 
DIASTOLIC 
BP AT 45 
MIN 
DIASTOLIC 
BP AT 60 
MIN 
ARTICAINE 
(Group A) 
Mean 79.2000 86.6000 80.4000 77.8000 79.4000 
Median 81.0000 87.0000 80.0000 78.0000 81.0000 
Mode 70.00 80.00 80.00 78.00 82.00 
Std. 
Deviation 
7.25412 5.25357 3.62706 4.15799 6.04060 
LIDOCAINE 
(Group B) 
Mean 81.6000 81.0000 76.0000 75.6000 81.0000 
Median 80.0000 88.0000 79.0000 76.0000 79.0000 
Mode 80.00 88.00 80.00 76.00 78.00 
Std. 
Deviation 
5.87272 10.03328 9.97775 4.08792 6.61648 
p-VALUE  .673 .398 .333 .200 .704 
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Table.11 MEAN RANKS FOR SYSTOLIC & DIASTOLIC BLOOD 
PRESSURE 
 
 
 
 
 
 
 GROUP N MEAN RANK 
SYSTOLIC BP BEFORE 
LA 
ARTICAINE 10 9.40 
LIDOCAINE 10 11.60 
DIASTOLIC BP BEFORE 
LA 
ARTICAINE 10 9.95 
LIDOCAINE 10 11.05 
SYSTOLIC BP AT 15 MIN 
ARTICAINE 10 10.80 
LIDOCAINE 10 10.20 
DIASTOLIC BP AT 15 
MIN 
ARTICAINE 10 11.60 
LIDOCAINE 10 9.40 
SYSTOLIC BP AT 30 MIN 
ARTICAINE 10 10.70 
LIDOCAINE 10 10.30 
DIASTOLIC BP AT 30 
MIN 
ARTICAINE 10 11.75 
LIDOCAINE 10 9.25 
SYSTOLIC BP AT 45 MIN 
ARTICAINE 10 11.55 
LIDOCAINE 10 9.45 
DIASTOLIC BP AT 45 
MIN 
ARTICAINE 10 12.15 
LIDOCAINE 10 8.85 
SYSTOLIC BP AT 60 MIN 
ARTICAINE 10 10.95 
LIDOCAINE 10 10.05 
DIASTOLIC BP AT 60 
MIN 
ARTICAINE 10 10.00 
LIDOCAINE 10 11.00 
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Graph.1 AGE OF THE PARTICIPANTS. (Years) 
 
 
 
 
Graph.2 NUMBER OF MALES AND FEMALES IN GROUPS 
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Graph.3 HEART RATE (Minutes) 
 
 
 
 
Graph.4 OXYGEN SATURATION (%) 
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Graph.5 SYSTOLIC BLOOD PRESSURE (mmHg) 
 
 
 
 
Graph.6 DIASTOLIC BLOOD PRESSURE (mmHg) 
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DISCUSSION 
           Local anaesthetics form the mainstay of pain control techniques in 
dentistry. The role of drugs used for local anaesthesia is vital in the field of 
dentistry as they help the dentists in the successful completion of various 
dental procedures by ensuring less pain and discomfort for the patients. It can 
be said that local anaesthesia forms the backbone of almost all dental 
procedures. Tooth extraction is one of the procedures that especially require a 
relatively pain-free arrangement. As effective as these drugs are, however, 
research has continued to seek safer and more effective local anaesthetics. 
Articaine is emerging local anesthetic which due to its comparable safety and 
potency has been studied extensively and being compared with Lignocaine. 
 
           Local anaesthetics provide adequate pain relief for the majority of 
dental procedures; however, failures do occur. These may be the result of 
anatomical, pharmacological, pharmaceutical, pathological, psychological or 
procedural factors (Byers et al. 1990, Wong & Jacobsen 1992, Quinn 1998, 
Hargreaves & Keiser 2002, Meechan 2005).29 The local infiltration 
anaesthesia (LIA) is significantly simpler compared to the nerve block 
techniques and less unpleasant for patients. However, it is not efficient if used 
for complicated exodontia like impacted tooth removal. Factors that affect 
both the depth and duration of a drug’s anesthetic action include individual 
response to drug, accuracy in deposition of local anesthetic, status of tissue at 
the site of drug deposition, anatomical variation and volume of anesthetic 
used. In this study, we used 4% Articaine with 1:100,000 epinephrine for the 
surgical removal of maxillary impacted canine due to its attributed effective 
pain control because of its better diffusion properties. Additionally, increased 
lipid solubility provides the enhanced diffusion through hard and soft tissues. 
This feature enables the passage of the anaesthetic even through thick cortical 
bone.   
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           Robertson et al.53 recorded a successful analgesia with Articaine 
administered via local infiltration anesthesia for mandibular posterior teeth 
ranging from 75% to 92%, which was significantly higher when compared to 
Lidocaine. Even more, supplemental local infiltration with Articaine after 
IANB with Lidocaine provided better pulpal anaesthesia of lower posterior 
teeth, enabling longer duration of anaesthesia of the first molar and second 
premolar. Robertson concluded that both local buccal infiltration and Inferior 
alveolar nerve block with Articaine proved to be highly successful, in the 
region of the first molars and both premolars. However, they found buccal 
infiltration was not as effective in mandibular second molar region. They 
attributed that the reasons being individual anatomical nature, such as the 
increased thickness of the buccal lamella in the region of the second molar, 
more lingual position of the mandibular canal, as well as the fact that the 
anaesthetic was applied proximal to the mentioned tooth. 
 
           Various authors have evaluated the success of mandibular first molar 
infiltrations using asymptomatic subjects, a cartridge of 4% Articaine with 
1:100,000 epinephrine, and an electric pulp tester to evaluate pulpal 
anaesthesia. Kanaa et al, Robertson et al, Jung et al, Corbett et al, Pabst et al, 
and McEntee et al used a similar methodology to the current study and showed 
64%, 87%, 54%, 64% to 70%, 64% to 69%, and 67% success rates, 
respectively. The results of previous studies confirm that the buccal infiltration 
of a 1.8 ml Articaine would not provide predictable pulpal anaesthesia of 
mandibular molars.16,31,53 
 
           Costa et al.11 carried out a study to compare the onset and duration of 
pulpal anaesthesia by maxillary infiltration using 2% Lidocaine with 
1:100,000 epinephrine, 4% Articaine with 1:200,000 epinephrine, and reported 
that both solutions produced shorter onset and longer duration of pulpal 
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anaesthesia. Sierra ‑ Rebolledo et al.51 carried out a comparative study on the 
anesthetic efficacy of 4% Articaine versus 2% Lidocaine, both with 
epinephrine 1:100,000, in truncal block of the inferior alveolar nerve during 
the surgical extraction of impacted lower third molars and found out that 4% 
Articaine offers better clinical performance than 2% Lidocaine, particularly in 
terms of latency and duration of the anesthetic effect but statistically no 
significant differences in anesthetic efficacy were recorded between the two 
solutions. Kalia et al. did a study to compare the onset and duration of 
anaesthesia of 4% Articaine with epinephrine (1:100,000) versus 2% 
Lidocaine with epinephrine during exodontias and concluded that there were 
some significant differences between 4% Articaine and 2% Lidocaine in terms 
of subjective and objective symptoms and onset of pulpal anaesthesia. The 
result showed that 4% Articaine had longer duration and onset of anaesthesia 
as compared to 2% Lidocaine. 
 
           The choice of anesthetic solution should be based on three main clinical 
considerations: anesthetic potency, latency (time to onset of anaesthesia), and 
duration of the anesthetic effect. Other important considerations are the 
pharmacokinetics (absorption, distribution, metabolization and excretion) and 
toxicity of the drug. The latency of Lidocaine varies from 2-3 minutes, with an 
approximate duration of anesthetic effect for 2% solutions with epinephrine 
1:100,000 as vasoconstrictor of 85 minutes at pulp level, and 190 minutes in 
soft tissues.52 Lidocaine is the local anesthetic most widely used for pain 
control, since its pharmacokinetic characteristics and low toxicity compared 
with other ester-type anaesthetics make it safe for use in dental practice. Its 
potency is presently regarded as the standard for comparison with other local 
anaesthetic. 
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Drug Volume 
 Malamed reported that the mean volume of Articaine required to 
achieve anaesthesia was 2.5 + 0.07 ml for simple procedures like single 
extractions (compared to 2.6ml + 0.09 of Lidocaine) and 4.2ml + 0.15 ml for 
complex procedures like multiple extractions, alveloectomies and other 
osseous procedures (compared to 4.5ml + 0.21 of Lidocaine).59 Sreekumar and 
Bhargava8 conducted a study to compare the onset and duration of action of 
soft tissue and pulpal anaesthesia with three different volumes 0.6 ml, 0.9 ml, 
and 1.2 ml of 4% Articaine with 1:100,000 epinephrine in maxillary 
anaesthesia and concluded that maxillary infiltration anaesthesia with 
Articaine and epinephrine has a faster onset, a greater success rate, and a 
longer duration with volume of 1.2 ml.55 In our study the mean drug volume 
was 1.9ml + 0.2ml for Group A and 2.2 ml  + 0.5ml for Group B administered 
via buccal and palatal infiltrations, statistically no significant difference was 
present in the two groups.  
 
Onset of Action 
Onset of action depends on a number of factors, such as the intrinsic 
properties of the drug substance used, and the anesthetic technique employed. 
On the other hand, latency is directly influenced by the corresponding pKa 
value—smaller pKa values being associated to shorter latency. Accordingly, 
4% Articaine (pKa = 7.8) would at least in theory present a shorter latency 
than 2 % Lidocaine (pKa = 7.9). Dugal et al.12 concluded onset of action of 
Lidocaine was 1.15 min when injected for nerve blocks. Moore et al. reported 
that the onset of action was 3.0 ± 2.1min 4 % for Articaine HCl with 
1:100,000 and 3.1 ± 2.3 min for 4 % Articaine HCl with 1:200,000 after 
maxillary infiltration of 1.0ml anesthetic solution.45 Colombini et al. stated 
149.50 ± 14.29 s for Articaine via IANB in lower third molar removal.9 
Rebolledo et al.52 reported 53.03 s (0.93 min) for Articaine versus 75.04 sec 
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(1.25 min) for Lidocaine in lower third molar removal. The mean onset of 
anaesthesia was 42.2 seconds for Group A and 60 seconds for    Group B 
which was given as buccal and palatal infiltrations in our study, there was 
statistically significant differences between the two groups. 
Duration of Anaesthesia 
           Duration of anaesthesia is directly proportional to its degree of protein 
binding. However, the duration of the effect of the local anesthetic is also 
dependent on the injection site or concentration of vasoconstrictor present in 
the anesthetic solution being used. Articaine presents the greatest protein 
binding capacity of all the amide local anaesthetics, comparable only to long 
acting substances such as Bupivacaine, Ropivacaine and Etidocaine. This in 
turn implies a longer duration of the anesthetic effect.65 The duration of 
anaesthesia required to complete the procedure will be major consideration in 
the selection of local anesthetic solution. Hass et al.28 and Costa et al.11 stated 
that 4% Articaine with 1:100,000 Epinephrine clinically presented the shortest 
onset and the longest duration periods and Articaine solutions produced both 
shortest onset and longer duration of pulpal anaesthesia in maxillary 
infiltration than the Lidocaine solution but statistically did not conform better 
clinical results.  
           Moore et al. reported mean duration of pulpal anaesthesia with 
infiltration was (A100) 61.8 + 59 minutes and (A200) 51.2 + 55.9 minutes 
evaluated by electric pulp testing and there were statistically significant 
differences between the two groups.45 In our study the mean duration of 
Anaesthesia was 120.8 min for Group A and 91.8 min for Group B by 
maxillary infiltration and there were statistically significant differences 
between the two groups, the results of the present study are in accordance with 
the above reported study. Colombini et al. concluded that the duration of 
anesthesia was 273.80 + 15.94 minutes for Mepivacaine. Rebolledo et al.50 
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reported 220.8 minutes for Articaine and while 168.2 minutes for Lidocaine 
Anaesthesia by inducing inferior alveolar nerve block anaesthesia. The long 
period of analgesia for Articaine stated that the concentration of Articaine in 
the alveolus of a tooth extraction is about 100 times higher than in systemic 
circulation. The saturable local Articaine mechanism has been considered as 
possibly contributing to the observed duration of local anesthetic effect.  
Depth of Anaesthesia 
          Depth of anaesthesia was made by means of a visual analogue scale 
(VAS) and was taken by a different operator to avoid influencing the patient 
intraoperatively during the procedure for scoring the pain intensity. In our 
study intraoperative VAS of 1–10 for Group A and Group B the results are 
statistically not significant (p > 0.639 at 15minutes and p > 0.135 at 30 
minutes interval) for Articaine and Lidocaine. According to Malamed et al, 
Rebolledo et al, Gregorio et al, reported the intra operative analgesia evoked 
by Articaine may be explained by its ability to readily diffuse through tissues 
due to the presence of thiophene group in the molecule which increases 
liposolubility.19,51 
 Efficacy of Articaine  
          In our study, clinical evaluation of the efficacy of the two anesthetic 
solutions were made by comparing the need for re-anesthesia during surgery. 
In one intervention another dose of Articaine was administered and in three 
interventions another dose of Lidocaine was administered during the 
procedure. However, mean drug volume used for re-anesthesia of the surgical 
area failed to reach statistical significance. Rebolledo et al,51 Potonick et al.49 
reported that 2 % Articaine more effectively depresses the compound action 
potential of the A fibers in the isolated rat sural nerve than either 2 % or 4 % 
Lidocaine or 3 % Mepivacaine. Paessler et al.23 concluded that the 4 % 
Articaine solution did not prove superior in local anesthetic effect. Articaine 2 
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% with epinephrine 1:200,000, therefore, can be considered a suitable local 
anesthetic for tooth extractions. The most noticeable difference observed 
between the two injection solutions concerned the duration of anaesthesia, 
which was significantly shortened under the low dose solution.  
           Santos et al.54 reported that epinephrine concentration in 4 % Articaine 
solution does not influence the clinical efficacy of local anesthetic in terms of 
anesthetic properties (latency, post-operative analgesia, post-operative 
anaesthesia and quality of anaesthesia), intra operative bleeding and 
hemodynamic parameters in patients undergoing lower third molar removal. 
Gregorio et al. stated that 4% Articaine provided shorter time of onset, 
comparable homeostasis and post-operative pain control with a shorter 
duration of soft tissue anaesthesia in lower third molar removal.  
          Uckan et al. and Lacet-Lima et al.29  Reported that Articaine 
demonstrated relatively good vestibule palatal diffusion with efficacy rates of 
anaesthesia 98%. Retained maxillary third molar extractions could be 
performed with only buccal vestibule infiltrative terminal anaesthesia in the 
majority of cases with no need for supplemental palatal anaesthesia. 
Hemodynamics 
          The major concern in dentistry is perioperative hypertension crisis in 
hypertensive patients. As hypertension can bring about complications such as 
paralysis, heart and renal problems, and acute medical problems. Hypertensive 
patients constitute an important risk group in dental treatment. Although it is 
stated in the literature that local anaesthetics with vasoconstrictors can be 
safely used during oral surgery in hypertensive patients, there are still some 
controversies about this subject. It has been reported that the use of anesthetic 
solutions without vasoconstrictors increase the risk of hypertensive crisis due 
to the potential pain caused by insufficient intraoperative anaesthesia. Most 
clinicians prefer using local anaesthetics without vasoconstrictors in 
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hypertensive patients due to the negative effects of vasoconstrictors on 
cardiovascular system. Therefore, hemodynamic aspects, like BP or heart rate 
(HR), in hypertensive patients come into prominence.50 
 
           In addition to HR and BP, myocardial ischemia is also important in 
hypertensive patients. Rate pressure product (RPP) and pressure rate quotient 
(PRQ) are described as the possible predictors of myocardial oxygen 
consumption and subsequent ischemia. RPP is defined as the product of 
systolic BP (SBP) and the HR, and PRQ is defined as the mean arterial 
pressure (MAP) divided by the HR. Significant values suggested for RPP 
range from 12,000 to 20,000 to indicate ischemia and over 20,000 to indicate 
angina pectoris. It must be noted that 75% of all episodes of myocardial 
ischemia is silent and develops without anginal symptoms. For this reason, an 
RPP of 12,000 seems to provide a reasonable target value when monitoring 
ischemia. The target value for PRQ has been determined to be less than 1.08.64 
          In patients with cardiovascular disorders, Anaesthesia with its lower 
epinephrine content is usually preferred with the aim of avoiding the systemic 
side effects of epinephrine. Epinephrine in anesthetic solutions causes local 
vasoconstriction and prolongs the duration of anaesthesia. The systemic 
effects of epinephrine in local anesthetic agents have been discussed. Plasma 
epinephrine concentrations have been shown to increase more than 10-fold 
after administration of 3.6 mL of 2% Lidocaine with 1:80,000 epinephrine. 
Despite increases in serum catecholamine concentrations, administration of 
local anesthetic agents appears to cause only minor hemodynamic changes. 
Twelve healthy patients can tolerate these abrupt increases in vasoconstrictor 
serum concentration, but patients with cardiovascular disease may not be able 
to; thus, less vasoconstrictor in the solution could be safer. However, it is 
generally agreed that epinephrine administration should be avoided when a 
patient’s cardiovascular status is labile. Evaluation of blood pressure and heart 
rate is one of the most sensitive assays for the response to epinephrine levels. 
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Our results show that both local anesthetic agents tested provide adequate 
anaesthesia rapidly and sufficiently long for minor dental procedures without 
any significant hemodynamic changes. We have not included any medically 
compromised patients in our study.23  
 
          In our present study the values of cardiovascular parameters showed that 
pulse rate increased with injection of 4 % Articaine and 2 % Lidocaine. The 
increase in pulse rate was maximum after 15 min of administration of 
Articaine and Lidocaine. The mean rise in Articaine group was 4 beats/min 
and gradually decreased to the basal value after 30 min. The mean rise in 
Lidocaine group was 6 beats/min and gradually decreased to the basal value 
after 30 min and no statistically significant differences between the two 
groups. The change in the systolic and diastolic blood pressure was recorded 
after administration of the local anesthetic agent and compared with the base 
line value in both the groups. There was no significant change noted in the 
systolic or diastolic blood pressure from the base line values at different time 
intervals after administration of both the anesthetic solutions. Our results are 
comparable with that of Santos et al.54  who reported that transient increase or 
decrease in blood pressure and oxygen saturation were observed but they were 
neither clinically significant nor statistically significant. Local anesthesia with 
epinephrine may cause a slight increase in blood glucose concentration in type 
II controlled diabetic patients, which is not found to be clinically significant 
and therefore safe to use on diabetic patients. Hence, we have not evaluated 
the blood glucose level in our study.  
 
Oxygen Saturation 
The change in oxygen saturation was recorded after administration of 
the local anesthetic agent and compared with the base line value in both the 
groups. There was no significant change noted in the oxygen saturation from 
the base line values at different time intervals after administration of both the 
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anesthetic solutions. Colombini et al, Santos et al, Martinez et al, Elad et al.  
reported in accordance to our result. Vasconcellos et al.  suggested that all 
patients submitted to surgery for removal of third molars are at risk for 
hypoxia. Short episodes of hypoxia may have only minor consequences in 
healthy patients, but those in unhealth may develop serious 
complications.10,20,54,64. 
Adverse Reactions 
          According to literature Articaine has the potential to cause 
methemoglobinemia, neuropathies, paraesthesia, hypersensitivity, allergy. 
Malamed et al. reported overall incidence of adverse events in the combined 
studies were 22 % for Articaine and 20 % Lidocaine of which paraesthesia 
was 0.9 %, hypoesthesia 0.7 %, headache 0.55 %, infection 0.45 %, rash and 
pain 0.3 %. Methemoglobinemia has been shown to develop with some types 
of local anaesthetics. Clinical tests of Articaine, Bupivacaine and Etidocaine 
administered as central nerve block anesthetic for urological procedures         
(n = 103) indicated no elevation of methemoglobin with Articaine.62 
 
          Haas and Lennon19 published a retrospective analysis of paresthesia 
after local anesthetic administration for nonsurgical dental procedures over a 
21-year period. The analysis revealed a higher-than-expected frequency of 
paresthesia with Articaine, based on the number of cartridges used (2.27 per   
1 million injections vs. an expected frequency of 1.20 per 1 million 
injections). Malamed et al also reported an increased incidence of nerve 
alterations, paresthesia’s and hyperesthesia’s, when administering 4% 
Articaine with epinephrine 1:100,000 versus 2% Lidocaine at the same 
vasoconstrictor concentration – suggesting a possible greater neurotoxic effect 
on the part of Articaine.7 In this sense, Penarrocha et al48 documented 14 cases 
of    eye   problems  when  using  this  anesthetic  for  infraorbital nerve  block.  
Discussion 
 
48 
 
Among the causes for these complications, the authors mentioned the 
possibility of increased diffusion of this anesthetic within the soft tissues and 
bone – thus facilitating Articaine penetration to the orbital cavity. 
 
          One of the most controversial aspects of Articaine administration is its 
potential to cause paresthesia’s after inferior alveolar nerve blockade, which 
leads some researchers to support the opinion that 4% Articaine should not be 
routinely used in this anesthetic application. Other authors attribute this 
adverse effect to the higher concentration of Articaine (4%) compared with 
other local anaesthetics (e.g., 2% Lidocaine in association with epinephrine). 
Interestingly, Haas and Lennon also observed the same side effect for 
Prilocaine, which is also available in the same concentration as Articaine. It 
may be possible to decrease the risk of paresthesia’s by using a lower 
concentration of Articaine to block the inferior alveolar nerve. However in our 
study we didn’t encounter any kind of complications20 
 
          Articaine is contraindicated in patients allergic to amide‑type 
anaesthetics and patients allergic to metabisulfites (preservative present in the 
formula to extend the life of epinephrine). It is contraindicated in patients with 
hemoglobinopathies (sickle cell disease) and in patients with idiopathic or 
congenital methemoglobinemia, but methemoglobinemia is not a concern in 
the dental practice due to the small volumes of Articaine used. In our study we 
did not encounter any kind of adverse reactions. 52         
 
          Articaine has few advantages over Lidocaine including being more 
potent due to its high lipid solubility, a long duration of action and having a 
higher rate of diffusion through both soft and hard tissue. Articaine causes a 
transient and completely reversible state of anaesthesia (loss of sensation) 
during dental procedures. Articaine is used both for infiltration and block 
injections, and  with  the  block  technique,  it yields  the  greatest duration of  
Discussion 
 
49 
 
anaesthesia.  Also, in people with hypokalemia and sensory overstimulation, 
Lidocaine is not very effective, but Articaine works well.52 Several studies 
have linked the use of Articaine to a lower level of pain in patients undergoing 
extractions. 
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SUMMARY AND CONCLUSION 
          The study was done to evaluate the anesthetic efficacy of 4% Articaine 
with 1:100,000 epinephrine for surgical removal of impacted maxillary canine. 
A total of twenty patients with impacted maxillary canine tooth were 
randomly allotted to either Group A (4% Articaine with 1:100,000 
epinephrine) or Group B (2% Lidocaine with 1:80,000 epinephrine) for 
surgical removal. From our study we concluded that, 
 
• The mean onset of Anaesthesia for articaine was 42 + 7 seconds which 
was significantly less than that of Lidocaine. 
• The mean duration  of Anaesthesia for articaine was 120 + 14 minutes 
which was significantly higher than that of Lidocaine. 
• The depth of anesthesia for surgical removal of canine tooth was 
adequate with Articaine and there was no significant difference when 
compared with Lidocaine. 
• There was no significant difference between Articaine and Lidocaine 
in terms of pain score and in hemodynamic changes. 
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Annexures 
 
 
 
 
ANNEXURE – I 
 
 
 
 
 
 
  
ANNEXURE - II 
INFORMED CONSENT FOR PARTICIPATION IN THE STUDY 
TO WHOM SO EVER IT MAY CONCERN 
 
Date: 
Place: 
 
I, ………………………………………. Give my consent to be interviewed and examined by 
the doctor(s). I agree to co-operate to any investigations considered necessary for the study. 
I have been informed about the study “EVALUATION OF CLINICAL EFFICACY OF 4% 
ARTICAINE WITH 1:100,000 EPINEPHRINE IN IMPACTED MAXILLARY CANINE.” 
 I have been explained about the nature of the study and the proposed procedure.  
I have been explained the nature and necessity of the proposed procedure to treat my 
condition/disease. I have been informed about the risks involved and the complications likely 
to arise during the procedure or thereafter, in the language I understand.  
I consent to the administration of such anesthetic as may be considered necessary or 
advisable for this service and to the performance of the procedure. I acknowledge that no 
guarantees have been given by anyone about the results of the procedure of medicine and 
surgery is not an exact science.  
I was free to ask questions and have been answered satisfactorily. I consent to the taking of 
photographs and publication of the same to advancing health education. I understand that my 
identity will remain confidential. 
 
 
 
 
Signature of the Patient                                               Signature of the Guardian     
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